Brion W Murray

Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2020-2021
Publications (10 Years): 3

Top Topics

Molecular Dynamics

Subarachnoid Hemorrhage

Chronic Myeloid Leukemia

Advanced Non Small Cell Lung Cancer

Top Venues

Molecular cancer therapeutics

Turning Point Therapeutics

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Turning Point Therapeutics Jun 17 2019

United States

Vice President :: Cancer Biology

Pfizer Global Research and Development Feb 07 2000 - Jun 18 2019

United States

Research Fellow :: Tumor Cell Biology

Celgene Corp Sep 04 1996 - Jan 27 2000

United States

Research Scientist :: Signal Pharmaceutical Research Division

Publications

Brion W Murray, Dayong Zhai, Wei Deng, Xin Zhang, Jane Ung, Vivian Nguyen, Han Zhang, Maria Barrera, Ana Parra, Jessica Cowell, Dong J Lee, Herve Aloysius, Evan Rogers
TPX-0131, a Potent CNS-penetrant, Next-generation Inhibitor of Wild-type ALK and ALK-resistant Mutations. Molecular cancer therapeutics 20 (9) (2021)
Brion W Murray, Evan Rogers, Dayong Zhai, Wei Deng, Xi Chen, Paul A Sprengeler, Xin Zhang, Armin Graber, Siegfried H Reich, Shanna Stopatschinskaja, Benjamin J Solomon, Benjamin Besse, Alexander E Drilon
Molecular Characteristics of Repotrectinib That Enable Potent Inhibition of TRK Fusion Proteins and Resistant Mutations. Molecular cancer therapeutics 20 (12) (2021)
Brion W Murray
Countering Breast Cancer's Counterpunch. Molecular cancer therapeutics 18 (10) (2020)